The focus of a Securities and Exchange Commission probe into the health of Steve Jobs is likely to concentrate on his sudden leave of absence, a source tells Bloomberg. The departure of the Apple CEO is viewed as sudden, having come just nine days after he admitted to a "hormonal imbalance" with simple if prolonged treatment. SEC efforts are being directed from a San Francisco office, the source
